Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma

Elisabet E. Manasanch; Preetesh Jain; Wendy Chen; Onyeka Oriabure; Maria Badillo; Lei Feng; Zuzana Berkova; Robert Z. Orlowski; Michael Wang

doi:10.1002/ajh.25858

Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma

Elisabet E. Manasanch, Preetesh Jain, Wendy Chen, Onyeka Oriabure, Maria Badillo, Lei Feng, Zuzana Berkova, Robert Z. Orlowski, Michael Wang

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	E232-E235
Journal	American journal of hematology
Volume	95
Issue number	9
DOIs	https://doi.org/10.1002/ajh.25858
State	Published - Sep 1 2020

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.25858

Cite this

@article{e954c5ed65004eb88415af7e28262ea9,

title = "Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma",

author = "Manasanch, {Elisabet E.} and Preetesh Jain and Wendy Chen and Onyeka Oriabure and Maria Badillo and Lei Feng and Zuzana Berkova and Orlowski, {Robert Z.} and Michael Wang",

note = "Funding Information: This work was supported in part by The MD Anderson Cancer Center Support Grant (P30 CA016672), the Leukemia and Lymphoma Society Specialized Center of Research (LLS SCOR), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the Multiple Myeloma Research Foundation, the Chapman Perelman Foundation and the University of Texas MD Anderson Moon Shot Program. RZO, the Florence Maude Thomas Cancer Research Professor, would like to acknowledge support from the National Cancer Institute (R01s CA184464 and 194264, and U10 CA032102), the Leukemia & Lymphoma Society (SCOR‐12206‐17), the Adelson Medical Research Foundation, the Brock Family Myeloma Research Fund, and the Jean Clarke High‐Risk Myeloma Research Fund. We would like to thank participating patients and their families. ",

year = "2020",

month = sep,

day = "1",

doi = "10.1002/ajh.25858",

language = "English (US)",

volume = "95",

pages = "E232--E235",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "9",

}

TY - JOUR

T1 - Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma

AU - Manasanch, Elisabet E.

AU - Jain, Preetesh

AU - Chen, Wendy

AU - Oriabure, Onyeka

AU - Badillo, Maria

AU - Feng, Lei

AU - Berkova, Zuzana

AU - Orlowski, Robert Z.

AU - Wang, Michael

N1 - Funding Information: This work was supported in part by The MD Anderson Cancer Center Support Grant (P30 CA016672), the Leukemia and Lymphoma Society Specialized Center of Research (LLS SCOR), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the Multiple Myeloma Research Foundation, the Chapman Perelman Foundation and the University of Texas MD Anderson Moon Shot Program. RZO, the Florence Maude Thomas Cancer Research Professor, would like to acknowledge support from the National Cancer Institute (R01s CA184464 and 194264, and U10 CA032102), the Leukemia & Lymphoma Society (SCOR‐12206‐17), the Adelson Medical Research Foundation, the Brock Family Myeloma Research Fund, and the Jean Clarke High‐Risk Myeloma Research Fund. We would like to thank participating patients and their families.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85086152667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086152667&partnerID=8YFLogxK

U2 - 10.1002/ajh.25858

DO - 10.1002/ajh.25858

M3 - Letter

C2 - 32390148

AN - SCOPUS:85086152667

SN - 0361-8609

VL - 95

SP - E232-E235

JO - American journal of hematology

JF - American journal of hematology

IS - 9

ER -

Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this